Tenaris S.A. Form 6-K Summary
Business Context and Reporting Period
Tenaris S.A., a leading global manufacturer of tubular products for the oil and gas industry, filed this Form 6-K on June 6, 2007. The filing reports on the outcomes of the company's annual and extraordinary general shareholders' meetings held on that date.
Key Financial Metrics
- Dividend Payment: An annual dividend of US$0.30 per share (US$0.60 per ADS) was approved, totaling approximately US$354 million.
- Payment Dates: The dividend is payable on June 21, 2007, with an ex-dividend date of June 18, 2007.
- Financial Statements: The meeting approved consolidated financial statements for the year ended December 31, 2006.
- Other Metrics: The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity for the period.
Material Changes and Corporate Actions
- Board Elections: The nine current board members were re-elected. Carlos Condorelli, Chief Financial Officer, was elected to the board until June 2008.
- Audit Committee: Amadeo Vazquez y Vazquez, Jaime Serra Puche, and Roberto Monti were confirmed as audit committee members, all of whom are independent directors. Mr. Vazquez y Vazquez continues as chairman.
- Auditor Appointment: PricewaterhouseCoopers was re-appointed as the independent auditor for the 2007 fiscal year.
- Share Capital: The validity of the authorized share capital was renewed for five years, authorizing the board to issue shares within that limit.
Guidance, Outlook, and Risks
The filing does not contain specific financial guidance, forward-looking outlook statements, or detailed risk factors beyond the standard corporate governance updates. No unusual items or contingencies were disclosed in this specific press release.
Investor Verification Checklist
- Verify the ex-dividend date of June 18, 2007, for eligibility to receive the US$0.30 per share dividend.
- Confirm the total dividend payout of approximately US$354 million against the company's cash position.
- Review the full 2006 consolidated financial statements approved at the meeting for detailed performance metrics.
- Monitor the implementation of the renewed share capital authorization for potential future dilution.